iX Biopharma Ltd. announced retirement of Ko Kheng Hwa as Lead Independent Director. His roles and responsibilities were Lead Independent Director, Chairman of Remuneration Committee and a member of Audit and Nominating Committees. Reason for cessation was Mr. Ko Kheng Hwa retired by rotation at the conclusion of the Annual General Meeting of the Company held on 19 October 2018 and did not offer himself for re-election.